Insider Trading Alert - SWX, ACT, SMG, HAL And MFRM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 13, 2013, 169 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $704.00 to $43,077,002,500.00.

Highlighted Stocks Traded by Insiders:

Southwest Gas Corporation (SWX) - FREE Research Report

DeBonis Eric who is SVP/Operations at Southwest Gas Corporation sold 1,500 shares at $53.97 on Nov. 13, 2013. Following this transaction, the SVP/Operations owned 17,186 shares meaning that the stake was reduced by 8.03% with the 1,500 share transaction.

The shares most recently traded at $53.55, down $0.42, or 0.78% since the insider transaction. Historical insider transactions for Southwest Gas Corporation go as follows:

  • 12-Week # shares sold: 1,000
  • 24-Week # shares sold: 4,538

The average volume for Southwest Gas Corporation has been 158,100 shares per day over the past 30 days. Southwest Gas Corporation has a market cap of $2.5 billion and is part of the utilities sector and utilities industry. Shares are up 26.06% year to date as of the close of trading on Tuesday.

Southwest Gas Corporation engages in the purchase, distribution, and transportation of natural gas in Arizona, Nevada, and California. The company operates in two segments, natural gas operations and construction services. The stock currently has a dividend yield of 2.45%. The company has a P/E ratio of 16.8. Currently there are 3 analysts that rate Southwest Gas Corporation a buy, 2 analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SWX - FREE

TheStreet Quant Ratings rates Southwest Gas Corporation as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and revenue growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Southwest Gas Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Actavis (ACT) - FREE Research Report

Bisaro Paul who is Chair,Pres &CEO at Actavis sold 40,921 shares at $158.73 on Nov. 13, 2013. Following this transaction, the Chair,Pres &CEO owned 399,995 shares meaning that the stake was reduced by 9.28% with the 40,921 share transaction.

Buchen David A who is Chief Legal Officer-Global&Sec at Actavis sold 30,000 shares at $159.30 on Nov. 13, 2013. Following this transaction, the Chief Legal Officer-Global&Sec owned 59,966 shares meaning that the stake was reduced by 33.35% with the 30,000 share transaction.

Paonessa Albert Iii who is President Anda, Inc. at Actavis sold 6,500 shares at $158.75 on Nov. 13, 2013. Following this transaction, the President Anda, Inc. owned 27,229 shares meaning that the stake was reduced by 19.27% with the 6,500 share transaction.

Stewart Robert A who is Pres-Global Operations at Actavis sold 12,000 shares at $158.39 on Nov. 13, 2013. Following this transaction, the Pres-Global Operations owned 59,252 shares meaning that the stake was reduced by 16.84% with the 12,000 share transaction.

Olafsson Sigurdur O who is Pres.-Actavis Pharma at Actavis sold 25,000 shares at $159.87 on Nov. 13, 2013. Following this transaction, the Pres.-Actavis Pharma owned 71,947 shares meaning that the stake was reduced by 25.79% with the 25,000 share transaction.

The shares most recently traded at $145.10, down $14.77, or 10.18% since the insider transaction. Historical insider transactions for Actavis go as follows:

  • 12-Week # shares sold: 69,013
  • 24-Week # shares sold: 145,976

The average volume for Actavis has been 1.1 million shares per day over the past 30 days. Actavis has a market cap of $18.6 billion and is part of the health care sector and drugs industry. Shares are up 62.01% year to date as of the close of trading on Monday.

Actavis plc, an integrated specialty pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally.

Exclusive Offer: Get the latest Stock Analysis on ACT - FREE

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Scotts Miracle Gro Co Class A (SMG) - FREE Research Report

Hagedorn James who is Chairman and CEO at Scotts Miracle Gro Co Class A sold 30,700 shares at $57.39 on Nov. 13, 2013. Following this transaction, the Chairman and CEO owned 58,575 shares meaning that the stake was reduced by 34.39% with the 30,700 share transaction.

Sanders Barry W who is President and COO at Scotts Miracle Gro Co Class A sold 6,045 shares at $57.51 on Nov. 13, 2013. Following this transaction, the President and COO owned 6,044 shares meaning that the stake was reduced by 50% with the 6,045 share transaction.

The shares most recently traded at $58.80, up $1.29, or 2.2% since the insider transaction. Historical insider transactions for Scotts Miracle Gro Co Class A go as follows:

  • 4-Week # shares sold: 88,512
  • 12-Week # shares sold: 116,064
  • 24-Week # shares sold: 897,700

The average volume for Scotts Miracle Gro Co Class A has been 288,600 shares per day over the past 30 days. Scotts Miracle Gro Co Class A has a market cap of $3.5 billion and is part of the basic materials sector and chemicals industry. Shares are up 31.31% year to date as of the close of trading on Tuesday.

The Scotts Miracle-Gro Company engages in manufacturing, marketing, and selling consumer lawn and garden care products. The stock currently has a dividend yield of 3.06%. The company has a P/E ratio of 20.5. Currently there are 2 analysts that rate Scotts Miracle Gro Co Class A a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SMG - FREE

TheStreet Quant Ratings rates Scotts Miracle Gro Co Class A as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Scotts Miracle Gro Co Class A Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Halliburton Company (HAL) - FREE Research Report

Brown James S who is President - Western Hemisphere at Halliburton Company sold 15,000 shares at $54.39 on Nov. 13, 2013. Following this transaction, the President - Western Hemisphere owned 338,520 shares meaning that the stake was reduced by 4.24% with the 15,000 share transaction.

The shares most recently traded at $55.54, up $1.15, or 2.07% since the insider transaction. Historical insider transactions for Halliburton Company go as follows:

  • 4-Week # shares sold: 30,170
  • 12-Week # shares sold: 140,791
  • 24-Week # shares sold: 217,802

The average volume for Halliburton Company has been 9.4 million shares per day over the past 30 days. Halliburton Company has a market cap of $46.9 billion and is part of the basic materials sector and energy industry. Shares are up 59.41% year to date as of the close of trading on Tuesday.

Halliburton Company provides a range of services and products for the exploration, development, and production of oil and natural gas to oil and gas companies worldwide. The company operates in two segments, Completion and Production, and Drilling and Evaluation. The stock currently has a dividend yield of 1.08%. The company has a P/E ratio of 26.5. Currently there are 18 analysts that rate Halliburton Company a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAL - FREE

TheStreet Quant Ratings rates Halliburton Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Halliburton Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Mattress Firm (MFRM) - FREE Research Report

Murphy Kenneth E. III who is Executive Vice President at Mattress Firm sold 3,500 shares at $35.00 on Nov. 13, 2013. Following this transaction, the Executive Vice President owned 65,249 shares meaning that the stake was reduced by 5.09% with the 3,500 share transaction.

McAndrews Craig who is Executive Vice President at Mattress Firm sold 833 shares at $33.59 on Nov. 13, 2013. Following this transaction, the Executive Vice President owned 19,984 shares meaning that the stake was reduced by 4% with the 833 share transaction.

The shares most recently traded at $35.01, up $1.42, or 4.06% since the insider transaction. Historical insider transactions for Mattress Firm go as follows:

  • 4-Week # shares sold: 500
  • 12-Week # shares sold: 9,088
  • 24-Week # shares sold: 1.3 million

The average volume for Mattress Firm has been 269,900 shares per day over the past 30 days. Mattress Firm has a market cap of $1.1 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 36.57% year to date as of the close of trading on Tuesday.

Mattress Firm Holding Corp., through its subsidiaries, operates as a specialty retailer of mattresses, and related products and accessories in the United States. The company has a P/E ratio of 24.6. Currently there are 6 analysts that rate Mattress Firm a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MFRM - FREE

TheStreet Quant Ratings rates Mattress Firm as a hold. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income and robust revenue growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and disappointing return on equity. Get the full Mattress Firm Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null